| NP0338690 | 3-phospho-hydroxypyruvate | |  | C3H2O7P
181.0175 Da
180.95381 Da | Not Available |
| NP0338691 | 2-oxo-3-phenylpropanoate | |  | C9H7O3
163.1501 Da
163.03952 Da | Not Available |
| NP0338692 | 4-hydroxybenzoate | |  | C7H5O3
137.1128 Da
137.02387 Da | Not Available |
| NP0338693 | 4-aminobenzoate | |  | C7H6NO2
136.1280 Da
136.03985 Da | Not Available |
| NP0338694 | TG(16:0/16:0/12:0) | |  | C47H90O6
751.2139 Da
750.67374 Da | Not Available |
| NP0338695 | TG(14:0/16:1(9Z)/18:1(9Z))[iso6] | |  | C51H94O6
803.3070 Da
802.70504 Da | Not Available |
| NP0338696 | TG(18:1(9Z)/18:1(9Z)/16:0) | |  | C55H102O6
859.3948 Da
858.76764 Da | Not Available |
| NP0338697 | ethyl 4-hydroxybutanoate | |  | C6H12O3
132.1577 Da
132.07864 Da | Not Available |
| NP0338698 | 1-Methylnicotinamide iodide | |  | C7H9IN2O
264.0636 Da
263.97596 Da | Not Available |
| NP0338699 | Isoestragole | |  | C10H12O
148.2050 Da
148.08882 Da | | 1H NMR Spectrum (1D, 90 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 15.09 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) |
|
| NP0338700 | (E)-methyl ester 3-phenyl-2-propenoic acid | |  | C10H10O2
162.1852 Da
162.06808 Da | |
| NP0338701 | Quercetin 3-O-acetyl-rhamnoside | |  | C23H22O12
490.4170 Da
490.11113 Da | Not Available |
| NP0338702 | Prostaglandin E-2 | |  | C20H32O5
352.4710 Da
352.22497 Da | Not Available |
| NP0338703 | 3-Methyl-L-histidine | |  | C7H11N3O2
169.1840 Da
169.08513 Da | Not Available |
| NP0338704 | (±)-Limonene diepoxide | |  | C10H16O2
168.2360 Da
168.11503 Da | Not Available |
| NP0338705 | Levothyroxine | |  | C15H11I4NO4
776.8740 Da
776.68669 Da | Not Available |
| NP0338706 | Silica gel | |  | H6OSi
50.1325 Da
50.01879 Da | Not Available |
| NP0338707 | Dihydrozeatin O-beta-D-Glucoside | |  | C16H25N5O6
383.4050 Da
383.18048 Da | Not Available |
| NP0338708 | Atractyligenin | |  | C19H28O4
320.4290 Da
320.19876 Da | Not Available |
| NP0338709 | PA(P-16:0e/18:2(9Z,12Z)) | |  | C37H69O7P
656.9133 Da
656.47809 Da | Not Available |
| NP0338710 | CL(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)) | |  | C85H146O17P2
1502.0061 Da
1501.00353 Da | Not Available |
| NP0338711 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z)) | |  | C47H78NO8P
816.0979 Da
815.54650 Da | Not Available |
| NP0338712 | CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:1(11Z)) | |  | C87H146O17P2
1526.0275 Da
1525.00353 Da | Not Available |
| NP0338713 | CL(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) | |  | C85H148O17P2
1504.0219 Da
1503.01918 Da | Not Available |
| NP0338714 | CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)) | |  | C85H146O17P2
1502.0061 Da
1501.00353 Da | Not Available |
